Core Viewpoint - Cigna Group reported mixed financial results for the fourth quarter of 2024, with adjusted earnings per share (EPS) missing estimates while revenues showed significant growth year over year [1][2]. Financial Performance - Adjusted EPS for Q4 2024 was 6.64,missingtheZacksConsensusEstimateby15.265.7 billion, surpassing the consensus mark by 3.9% [2]. - Total benefits and expenses rose 29% year over year to 63.5billion,drivenbyhigherpharmacyandmedicalcosts[4].−Adjustedoperatingincomefell81.8 billion, primarily due to reduced contributions from the Cigna Healthcare unit [4]. Customer Base and Segments - Cigna's medical customer base decreased by 3.2% year over year to 19.15 million, falling short of the consensus estimate [3]. - Evernorth Health Services segment reported adjusted revenues of 53.7billion,a3351.1 billion [5]. - Cigna Healthcare segment's adjusted revenues grew 3% year over year to 13.3billionbutmissedtheconsensusestimate[7].CostandMarginAnalysis−Theadjustedpre−taxmarginforoperatingincomedeterioratedby70basispointsyearoveryearto47.6 billion, a decrease of 3.5% from the previous year [9]. - Total assets increased by 2% to 155.9billion,whiletotalshareholders′equitydecreasedby11.241 billion [9]. Capital Deployment - Cigna repurchased 20.9 million shares for approximately 7billionin2024andincreaseditssharerepurchaseauthorizationto10.3 billion [12]. - An 8% increase in the quarterly cash dividend was approved, raising it to 1.51pershare[12].2025Outlook−Adjustedrevenuesfor2025areprojectedtobeatleast252 billion, indicating a minimum growth of 2% from 2024 [13]. - Adjusted operating income is expected to be a minimum of 7.9billion,reflectingagrowthofatleast2.129.50, suggesting a growth of at least 7.9% from 2024 [13].